Clinton Group says private equity firm could pay $23 per share for Nutrisystem In a letter to Nutrisystem, Clinton Group said, "We stand by our suggestions to do a leveraged buyback or increase the dividend today, but recognize that such transactions may not be enough to cure the valuation discount in the equity markets. We believe therefore the Board should consider carefully whether Nutrisystem should remain a public company at all. We are aware of private equity firms that are interested in discussing a buyout in which the current management team would remain in place but the company would be privately held. Given the Nutrisystem's superior brand and cash flow prospects for the business, we believe such a going-private transaction could garner a substantial premium for the public market investors while affording the private equity buyer of Nutrisystem attractive returns. We have modeled that a private equity firm could pay $23 per share for Nutrisystem (a 50% premium to today's prevailing prices) and still reasonably expect to earn an IRR above 20%. In the meantime, we urge the company to use its cash to buy back its own stock at these attractive prices. Obviously, the more stock that you buy at these prices, the more a private equity buyer can pay in a going-private transaction for the remainder of the outstanding stock."